基于CARC评价中西医结合治疗COVID-19病例报告质量  

Quality assessment on the case reports of COVID-19 treated with integrated traditional Chinese and Western medicine based on CARC

作　　者：肖璐[1] 牛丽青 付姝菲[2] 孙崇翔 李桂伟[1] 刘学政[1] 石存忠[1] XIAO Lu;NIU Liqing;FU Shufei;SUN Chongxiang;LI Guiwei;LIU Xuezheng;SHI Cunzhong(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China;Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)

机构地区：[1]天津中医药大学第一附属医院,天津300381 [2]天津中医药大学,天津301617

出　　处：《天津中医药》2021年第5期548-555,共8页Tianjin Journal of Traditional Chinese Medicine

基　　金：国家中医药管理局第四批全国中医优秀人才研修项目(国中医药办人教函[2017]24)。

摘　　要：[目的]分析截止2020年3月15日国内发表的中西医结合治疗新型冠状病毒肺炎(COVID-19)的病例报告质量,为提高国际突发公共卫生事件的病案报告质量提供依据,并为今后的临床实践和研究提供方法学参考。[方法]通过检索知网、万方数据库自2020年1月1日-3月15日所发表的相关文献,筛选出相关病例报告,根据中医药病案报告规范(CARC)工作组制定的《中医药病案报告发表规范专家共识》对纳入文献进行质量评价,计算含每条项目的论文报告比例。[结果]共纳入16篇病例报告,涉及病案30则,纳入病例报告的摘要及关键词、研究背景、患者一般情况、四诊收集、诊断及治疗等内容汇报较为完整,但中医病例报告仍存在缺陷,部分报告项目缺乏,大约56.3%的病例报告标题含有"病案"字样及报告病案的例数,研究背景中仅有18.8%的病例报告涉及知情同意方面的内容,而病例报告的诊断大都缺乏明确的诊断依据,在中药汤剂治疗中,62.5%的处方没有准确记录汤剂的用法用量,对中药饮片的产地及质量控制的相关记录更是凤毛麟角,涉及中成药治疗的4则病案也缺乏药品质量控制的标准,讨论部分约43.8%的文章对选方依据进行了阐述,仅有37.5%的文章阐明方解。[结论] COVID-19中西医结合治疗的相关病例报告整体质量有待进一步提高,以有利于COVID-19的中西医结合治疗从经验向循证实践发展,并为COVID-19诊治的相关高级别临床研究提供更佳参考和依据。[Objective] To analyze the quality of case reports for treatment of coronavirus disease 2019(COVID-19) with integrated traditional Chinese and Western medicine currently published in China,and to provide a basis for improving the quality of case reports for public health emergency of international concern(PHEIC),and to provide methodological references for future clinical practice and research. [Methods] Through searching the relevant literature published on CNKI and WanFang databases from January 1,2020 to March 15,2020,and screened out relevant case reports. According to Expert Consensus on the Standardization of Publication of Medical Record Reports in Traditional Chinese Medicine formulated by CARC,the quality of included literature were evaluated,and the proportion of paper reports containing each item were calculated. [Results] A total of 16 case reports were included,involving 30 medical records. The abstract and keywords of the case reports,research background,general patient status,four-diagnosis collection,diagnosis and treatment were relatively complete. However,the Traditional Chinese Medicine(TCM) case reports still had defects and some of the reported items were lacked. About 56.3% of the case reports contain both the word "medical record " in the title and the number of reported medical cases. Only 18.8% of the case reports in the research background involve the content of informed consent. Most cases lacked obvious diagnosis criteria. In the treatment of traditional Chinese medicine decoction,62.5% of the prescriptions did not accurately record the usage and dosage of the decoction,and the relevant records of the origin and quality control of Chinese medicine decoction pieces are even rarer. The 4 medical records involving the treatment of Chinese patent medicine also lack the standards for medicine quality control. In the discussion part,about 43.8% of the articles elaborated on the basis of the selection,and only 37.5% of the articles clarified the prescription explanation. [Conclusion] The over

关 键 词：病例报告 新型冠状病毒肺炎 中医药病案报告规范 中西医结合治疗 质量评价 

分 类 号：R511[医药卫生—内科学]